Revium Rx RVRC
OTC RVRC
$1.43 +0.00 (+0.00%)
At close: Oct 1, 2026 · 4:00 PM EDT

Revium Rx (RVRC) Other Non Operating Income (2026)

Updated

Revium Rx (RVRC) recorded Other Non Operating Income of -$16,000 in Q2 2026.

Analysis

Revium Rx (RVRC) Other Non Operating Income (2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Revium Rx 86.84 Mn 86.00 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -16,000.00
API Access

Revium Rx Other Non Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-operating-income&ticker=RVRC&period=max&api_key=YOUR_API_KEY